Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Cancer Chemotherapy and Pharmacology|September 6, 2019
Dose escalation study of amrubicin and cisplatin with concurrent thoracic radiotherapy for limited-disease small cell lung cancerMidori Shimada, Hiroyuki Yamaguchi, Minoru Fukuda, et al.
Lung Cancer Management|June 7, 2023
Proportion of biopsy specimens containing a tumor when compared to all biopsy specimens by transbronchial biopsyShinnosuke Takemoto, Mutsumi Ozasa, Remi Mizuta, et al.
Thoracic Cancer|February 19, 2021
Remarkable response to pembrolizumab with platinum-doublet in PD-L1-low pulmonary sarcomatoid carcinoma: A case reportHirokazu Taniguchi, Shinnosuke Takemoto, Mutsumi Ozasa, et al.
Thoracic Cancer|July 13, 2021
Efficacy of S-1 after pemetrexed in patients with non-small cell lung cancer: A retrospective multi-institutional analysisShinnosuke Takemoto, Kazumasa Akagi, Sawana Ono, et al.
Clinical Lung Cancer|June 11, 2018
Characterization of Computed Tomography Imaging of Rearranged During Transfection-rearranged Lung CancerMasafumi Saiki, Satoru Kitazono, Takahiro Yoshizawa, et al.
Thoracic Cancer|December 19, 2019
Phase II study of ramucirumab and docetaxel for previously treated non-small cell lung cancer patients with malignant pleural effusion: Protocol of PLEURAM studyShinnosuke Takemoto, Minoru Fukuda, Hiroyuki Yamaguchi, et al.
Journal of Thoracic Disease|October 29, 2025
A phase II clinical trial on the efficacy and safety of carboplatin plus nab-paclitaxel in chemotherapy-naive advanced or recurrent thymic epithelial tumors: protocol of Nab-TETFumiko Hayashi, Midori Matsuo, Shinnosuke Takemoto, et al.
Journal of Clinical Medicine|September 28, 2021
Real-World Incidence of Febrile Neutropenia among Patients Treated with Single-Agent Amrubicin: Necessity of the Primary Prophylactic Administration of Granulocyte Colony-Stimulating FactorYosuke Dotsu, Hiroyuki Yamaguchi, Minoru Fukuda, et al.
Translational Oncology|March 19, 2026
Genomic landscape of pleural mesothelioma in Japanese patients: A comprehensive analysis using nationwide databaseHirokazu Taniguchi, Kazumasa Akagi, Takahito Fukuda, et al.
Thoracic Cancer|July 17, 2019
Phase II study of nedaplatin and amrubicin as first-line treatment for advanced squamous cell lung cancerHirokazu Taniguchi, Hiroyuki Yamaguchi, Yosuke Dotsu, et al.
Pageof 4